// company-profile

Hemab Therapeutics Holdings, Inc.

COAG
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings9Insiders10
// api This Hemab Therapeutics Holdings, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 2 insiders purchased shares (net $1.7M). Buying was led by RA CAPITAL MANAGEMENT, L.P..

// 90-day insight

Over the last 90 days, Hemab Therapeutics Holdings, Inc. insiders bought $55.5M across 18 transactions with no open-market sales.

  • Most active insider: RA CAPITAL MANAGEMENT, L.P. with 25 transactions totaling $55.5M.
  • Largest single purchase: $45.7M by RA CAPITAL MANAGEMENT, L.P. on May 4, 2026.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 16, 2026RA CAPITAL MANAGEMENT, L.P.COAG
Purchase
61,523$24.98$1.54M
Jun 15, 2026RA CAPITAL MANAGEMENT, L.P.COAG
Purchase
6,146$24.89$153K
May 20, 2026RA CAPITAL MANAGEMENT, L.P.COAG
Purchase
996$24.94$25K
May 19, 2026RA CAPITAL MANAGEMENT, L.P.COAG
Purchase
3,802$24.97$95K
May 12, 2026RA CAPITAL MANAGEMENT, L.P.COAG
Purchase
6,387$24.90$159K

34 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.